Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CardioVasc implants endothelialisation stent:

This article was originally published in Clinica

Executive Summary

A German team has performed the first human implantation of a new stent-graft designed to promote rapid endothelialisation of the device. The product, developed by CardioVasc, of Menlo Park, California, was implanted by researchers from Kerckhoff Heart Center in Bad Nauheim. The low-profile, highly flexible device incorporates a surface treatment technology for enhancing endothelial cell adhesion after implantation, says CardioVasc, which is developing small diameter vascular stent-graft and surface technologies for promoting endothelialisation of implants. The product will initially be targeted at the treatment of lesions in saphenous vein grafts.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT071681

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel